The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it r...
The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone.
Author: NPR
Read Original Article